Global Lancets Market

Global Lancets Market was valued at US$ 774.2 Mn in 2019 and is expected to reach US$ 1832.7 Mn by 2027, at a CAGR of 11.37 % during the forecast period. The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.

Global Lancets Market

To know about the Research Methodology:Request Free Sample Report

Global Lancets Market Dynamics:

Lancets are being used for diabetes or glucose test, tests in infants, heel-stick screening tests, as well as for scarred emergency patients or harshly burned patients. The factors driving the market growth include increasing incidence rate of contagious and non-contagious diseases, growing prevalence of diabetes, and rising inclination towards home care and home diagnostics. However, the risk associated with blood transfusion and poor reimbursement scenario in developing countries is expected to hamper the market growth during the forecast period.

Global Lancets Market Segment Analysis:

The hospitals and clinics segment accounted for the largest share of the lancets market in 2019. This segment is primarily attributed to the availability of a large patient pool and the growing prevalence of infectious diseases that require blood testing for diagnosis and treatment.

Global Lancets Market Regional Insights:

Region-wise, the North American market for Lancet is expected to grow at a CAGR of 11.2% during the forecasted period. This is because of the increasing prevalence of diabetic patients. Europe is the second-largest market for Lancet with a market value of US$ 732.2 Mn in 2019. Whereas the Asia Pacific is expected to lead the Lancet market and to grow at a rapid rate. A recent development in Global Lancets Market: In October 2017, Abbott Laboratories announced the USA Food & Drug Administration appreciation for Abbott’s FreeStyle Libre Flash Glucose Monitoring System for adults. This product approval goals at enhancing the company’s products offering. In August 2017, HTL-STREFA S.A donated safety lancets to the GLOBAL-MED organization in Poland, which created an enterprise called ‘Ambulans z serca’ (Ambulance from the heart), to perform free glucose screenings during healthcare events. With this, the company goals to expand its customer base, so strengthening its presence in the market. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Lancets Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Lancets Market.

Global Lancets Market, Key Highlights:

• Global Lancets Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Lancets Market • Global Lancets Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Lancets Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Lancets Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Lancets Market are also profiled.

Scope of the Global Lancets Market Report: Inquire before buying

Global Lancets Market, By Type

• Safety Lancets o Push-Button Lancets o Pressure-Activated Lancets o Side-Button Lancets • Personal Lancets

Global Lancets Market, By Application

• Glucose Testing • Hemoglobin Testing • Coagulation Testing • Other Applications

Global Lancets Market, By End User

• Hospitals & Clinics • Home Care Settings • Other End Users

Global Lancets Market, By Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Key Players Operating in the Global Lancets Market :

• Becton, Dickinson and Company • Roche Diagnostics • Ypsomed • B. Braun Melsungen • Terumo Corporation • Owen Mumford • HTL-Strefa S.A • Arkray • Sarstedt • Sterilance Medical (Suzhou) • Medline Industries • Intrinsyk • I-SENS • Nipro • Omron • Infopia • Terumo Corporation • Bayer AG • Abbott Laboratories • F. Hoffmann-La Roche Ltd • Greiner Bio-One International GmbH • Improve Medical Instruments Co. Ltd • Lifescan • AgaMatrix • Smiths Medical • SANNUO • Yicheng • Yuwell • Edan • Narang Medical

Author: Web Spangle

Leave a Reply

Your email address will not be published. Required fields are marked *